Norovirus infection future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


== References ==
==Overview==
Clinically approved vaccines are to be investigated for the norovirus infection.
==Future or Investigational Therapies==
A significant limitation to the event of effective control measures has been the lack of a completely permissive [[cell culture]] system and little [[animal model]] for human noroviruses. Up until now, numerous developments has taken place, yet a licensed [[vaccine]] or clinically approved antiviral remains elusive. It would be invaluable to develop an [[in vitro]] culture system and an [[animal model]] that recapitulates all aspects of the infection as it is in humans. This remains a high priority, as it gives us a much better understanding of the correlates of protection and will enable better vaccine design, eventually leading to the development of a broadly protective [[vaccine]] for at least particularly vulnerable or regularly exposed individuals. Until then, effective [[quarantine]] and deployment of [[hygiene]] measures will help control norovirus [[Outbreak|outbreaks]] and minimize its impact on human health.<ref name="pmid24199805">{{cite journal| author=Arias A, Emmott E, Vashist S, Goodfellow I| title=Progress towards the prevention and treatment of norovirus infections. | journal=Future Microbiol | year= 2013 | volume= 8 | issue= 11 | pages= 1475-87 | pmid=24199805 | doi=10.2217/fmb.13.109 | pmc=3904215 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24199805  }} </ref>
==References==
{{Reflist|2}}
{{Reflist|2}}



Latest revision as of 15:00, 29 January 2021

Norovirus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Norovirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Norovirus infection future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Norovirus infection future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Norovirus infection future or investigational therapies

CDC on Norovirus infection future or investigational therapies

Norovirus infection future or investigational therapies in the news

Blogs on Norovirus infection future or investigational therapies

Directions to Hospitals Treating Norovirus infection

Risk calculators and risk factors for Norovirus infection future or investigational therapies

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Clinically approved vaccines are to be investigated for the norovirus infection.

Future or Investigational Therapies

A significant limitation to the event of effective control measures has been the lack of a completely permissive cell culture system and little animal model for human noroviruses. Up until now, numerous developments has taken place, yet a licensed vaccine or clinically approved antiviral remains elusive. It would be invaluable to develop an in vitro culture system and an animal model that recapitulates all aspects of the infection as it is in humans. This remains a high priority, as it gives us a much better understanding of the correlates of protection and will enable better vaccine design, eventually leading to the development of a broadly protective vaccine for at least particularly vulnerable or regularly exposed individuals. Until then, effective quarantine and deployment of hygiene measures will help control norovirus outbreaks and minimize its impact on human health.[1]

References

  1. Arias A, Emmott E, Vashist S, Goodfellow I (2013). "Progress towards the prevention and treatment of norovirus infections". Future Microbiol. 8 (11): 1475–87. doi:10.2217/fmb.13.109. PMC 3904215. PMID 24199805.


Template:WikiDoc Sources